Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Supplement—April 2025
SUPPLEMENT ISSUE
Supplement

Integrating Genomic Data into Public Health Surveillance for Multidrug-Resistant Organisms, Washington, USA

Laura Marcela Torres1Comments to Author , Jared Johnson1, Audrey Valentine1, Audrey Brezak, Emily C. Schneider, Marisa D’Angeli, Jennifer Morgan, Claire Brostrom-Smith, Chi N. Hua, Michael Tran, Darren Lucas, Joenice Gonzalez De Leon, Drew MacKellar, Philip Dykema, Kelly J. Kauber, and Allison Black
Author affiliation: Washington State Department of Health, Shoreline, Washington, USA (L.M. Torres, J. Johnson, A. Valentine, A. Brezak, E.C. Schneider, M. D’Angeli, C.N. Hua, M. Tran, D. Lucas, J. Gonzalez De Leon, D. Mackellar, P. Dykema, K.J. Kauber, A. Black); Public Health Seattle and King County, Seattle, Washington, USA (J. Morgan, C. Brostrom-Smith)

Main Article

Figure 7

Healthcare encounters at facilities of interest among carbapenemase-producing Acinetobacter baumannii OXA-235 cases as part of study of integrating genomic data into public health surveillance for multidrug-resistant organisms, Washington, USA. Six cases (14, 15, 16, 17, 18, and 19) are linked to a screening event at HF V, and 3 cases (5, 7, and 10) are linked to a screening event at HF I. Cases cannot be in 2 or more health facilities simultaneously. However, we only have access to admission and discharge dates; therefore, the figure may show some cases in multiple locations at the same time if transfers occurred without an associated admission and discharge. HF, health facility.

Figure 7. Healthcare encounters at facilities of interest among carbapenemase-producing Acinetobacter baumannii OXA-235 cases as part of study of integrating genomic data into public health surveillance for multidrug-resistant organisms, Washington, USA. Six cases (14, 15, 16, 17, 18, and 19) are linked to a screening event at HF V, and 3 cases (5, 7, and 10) are linked to a screening event at HF I. Cases cannot be in 2 or more health facilities simultaneously. However, we only have access to admission and discharge dates; therefore, the figure may show some cases in multiple locations at the same time if transfers occurred without an associated admission and discharge. HF, health facility.

Main Article

1These first authors contributed equally to this article.

Page created: March 06, 2025
Page updated: April 24, 2025
Page reviewed: April 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external